POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 8 | / | 2023 | ||||||||
Date of issue: | 2023-03-16 | ||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka, d. d., Novo mesto for 2022 | |||||||||||
Official market - legal basis | |||||||||||
art. 17. 1 MAR. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto publishes 2022 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka d. d., Novo mesto with relavant notes. The report will be published on the Company's website (www.krka.biz) from 16 March 2023 onwards, for a period of at least 5 years. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Unaudited consolidated financial statements of the Krka Group and the Krka company for 2022.pdf | Unaudited consolidated financial statements of the Krka Group and the Krka company for 2022 | ||||||||||
Press Release.pdf | Press Release |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nie dotyczy | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2023-03-16 | Jože Colarič | President of the Management Board and CEO |